A phase three clinical trial is being conducted here to evaluate the safety and efficacy of a new quadrivalent dengue vaccine ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

The authors investigated the potential role of IgG N-glycosylation in Haemorrhagic Fever with Renal Syndrome (HFRS), which may offer significant insights for understanding molecular mechanisms and for ...

The report, which covered the week of June 16-22, revealed that 781 confirmed cases were reported out of 5,943 suspected cases across 20 states and 101 LGAs ...

Viral haemorrhagic fevers (VHFs) are currently at the forefront of the world's attention due to the recent Zaire ebolavirus epidemic in West Africa. This epidemic has highlighted the frailty of the ...

Introduction Several societies have produced and disseminated clinical practice guidelines (CPGs) for the symptomatic management of fever in children. However, to date, the quality of such guidelines ...

The Indiana Fever can't extend their winning streak as the Los Angeles Sparks rally in the closing minutes.